1. Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy
    Andy Samuel Widjaya et al, 2022, Journal of Controlled Release CrossRef
  2. Blocking inhibition to YAP by ActinomycinD enhances anti-tumor efficacy of Corosolic acid in treating liver cancer
    Yanfeng Xu et al, 2017, Cellular Signalling CrossRef
  3. The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma
    Yi Xiao et al, 2020, Cancer Cell International CrossRef
  4. The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP‐C1 prostate cells
    Jie Yang et al, 2018, Molecular Carcinogenesis CrossRef
  5. MCL-1 is the key target of adjuvant chemotherapy to reverse the cisplatin-resistance in NSCLC
    Jun Ma et al, 2016, Gene CrossRef
  6. Targeted and Therapeutic Efficacy of 5-Fluorouracil-Loaded Polylactic Acid Nanocomplexes in Gastric Cancer
    Guangsi He et al, 2024, Journal of Biomedical Nanotechnology CrossRef
  7. Corosolic acid reduces 5‑FU chemoresistance in human gastric cancer cells by activating AMPK
    Jun Park et al, 2018, Molecular Medicine Reports CrossRef
  8. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs
    Xuqian Li et al, 2020, Acta Biomaterialia CrossRef
  9. Triterpenoid corosolic acid modulates global CpG methylation and transcriptome of tumor promotor TPA induced mouse epidermal JB6 P+ cells
    Rasika R. Hudlikar et al, 2020, Chemico-Biological Interactions CrossRef
  10. Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression
    Fei-Feng Tang et al, 2023, BMC Complementary Medicine and Therapies CrossRef
  11. Corosolic acid impairs human lung adenocarcinoma A549 cells proliferation by inhibiting cell migration
    Biao Li et al, 2019, Oncology Letters CrossRef
  12. An Update on the Effect of Natural Products on Oncogenic Transcription Factors in Triple Negative Breast Cancer
    Ashwathi Vijayalekha et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
  13. Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade
    Ke Wang et al, 2020, Frontiers in Pharmacology CrossRef